Loading insider details...
Beta
Latest Form 4 (Sep 4, 2026): Sale of 520 KRYS shares, $184.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 4, 2026 | Krystal Biotech, Inc. (KRYS) | Sale | 520 | $184.4K |
| Jun 5, 2026 | Krystal Biotech, Inc. (KRYS) | Sale | 320 | $96.2K |
| Mar 6, 2026 | Krystal Biotech, Inc. (KRYS) | Sale | 407 | $104.7K |
| Mar 3, 2026 | Krystal Biotech, Inc. (KRYS) | Exercise/Conversion | 22,500 | n/a |
| Dec 5, 2025 | Krystal Biotech, Inc. (KRYS) | Sale | 700 | $150.0K |
| Jul 16, 2025 | Krystal Biotech, Inc. (KRYS) | Sale | 13,335 | $2.00M |
| Jul 11, 2025 | Krystal Biotech, Inc. (KRYS) | Sale | 200 | $30.0K |
| Mar 13, 2025 | Krystal Biotech, Inc. (KRYS) | Sale | 1,639 | $288.4K |
| Mar 1, 2025 | Krystal Biotech, Inc. (KRYS) | Tax Withholding | 3,286 | $579.6K |
| Dec 13, 2024 | Krystal Biotech, Inc. (KRYS) | Sale | 5,942 | $968.8K |